What do drug monopolies cost consumers in developing countries?

This paper quantifi es the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.

MoreLess

Year of publication:	2011
Authors:	Hellerstein, Rebecca
Publisher:	New York, NY : Federal Reserve Bank of New York
Subject:	intellectual property rights \| international price discrimination \| TRIPS agreement \| pharmaceutical industry \| markups

freely available

Full text |

More access options

Check Google Scholar

In German libraries (KVK)

I need help

More details

Series:	Staff Report ; 530
Type of publication:	Book / Working Paper
Type of publication (narrower categories):	Working Paper
Language:	English
Other identifiers:	683159143 [GVK] hdl:10419/60909 [Handle]
Classification:	D4 - Market Structure and Pricing ; F13 - Commercial Policy; Protection; Promotion; Trade Negotiations ; L1 - Market Structure, Firm Strategy, and Market Performance ; L65 - Chemicals; Rubber; Drugs; Biotechnology ; O34 - Intellectual Property Rights: National and International Issues
Source:	EconStor

Persistent link: https://www.econbiz.de/10010287143